- Effect of Bevacizumab and Ranibizumab on the Expression of eNOS in Trabecular Meshwork Cells
-
Kim SE, Kim JW
- KMID: 2338861
- J Korean Ophthalmol Soc.
- 2014 Aug;55(8):1208-1212.
PURPOSE: To compare the effects of bevacizumab and ranibizumab on the expression of eNOS in cultured human trabecular meshwork cells (HTMC). METHODS: Primarily cultured HTMC were exposed to 0.5 mg/mL bevacizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Primary Intravitreal Ranibizumab Injection for Treatment of Type 1 Retinopathy of Prematurity
-
Chung GC, Moon SH
- KMID: 2390072
- J Korean Ophthalmol Soc.
- 2017 Sep;58(9):1080-1086.
- doi: 10.3341/jkos.2017.58.9.1080
PURPOSE: To evaluate the effectiveness and safety of primary intravitreal ranibizumab injection as a treatment for retinopathy of prematurity. METHODS: Retrospective analysis of the medical records of patients diagnosed with retinopathy... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Ranibizumab Injection in Adult-onset Coats' Disease: A Case Report
-
Kim HU, Shin SH, Park SP
- KMID: 2387164
- J Korean Ophthalmol Soc.
- 2017 Jul;58(7):870-874.
- doi: 10.3341/jkos.2017.58.7.870
PURPOSE: To report a case of adult-onset Coats' disease which showed decreased retinal edema and improved visual acuity following intravitreal ranibizumab injection. CASE SUMMARY: A 21-year-old woman visited our hospital for... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
-
Son BK, Kwak HW, Kim ES, Yu SY
- KMID: 2379877
- Korean J Ophthalmol.
- 2017 Jun;31(3):209-216.
- doi: 10.3341/kjo.2015.0158
PURPOSE: To assess the effectiveness and safety of intravitreal ranibizumab compared with bevacizumab for the treatment of macular edema associated with branch retinal vein occlusion (BRVO). METHODS: This was a retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Three Aflibercept Injections for Neovascular Age-related Macular Degeneration Showing Limited Response to Ranibizumab
-
Kim KM, Kim JH, Chang YS, Kim JW, Kim CG, Lee DW
- KMID: 2367843
- J Korean Ophthalmol Soc.
- 2017 Jan;58(1):62-68.
- doi: 10.3341/jkos.2017.58.1.62
PURPOSE: To evaluate the efficacy of 3 bimonthly aflibercept injections for neovascular age-related macular degeneration (AMD) that showed limited response to 3 initial ranibizumab injections. METHODS: Three bimonthly aflibercept injections were... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept
-
Moon TK, Ha JY, Sung MS, Park SW
- KMID: 2443153
- J Korean Ophthalmol Soc.
- 2019 Apr;60(4):362-368.
- doi: 10.3341/jkos.2019.60.4.362
PURPOSE: To evaluate long-term intraocular pressure (IOP) and risk of IOP elevation after intravitreal injection of ranibizumab or aflibercept in patients with age-related macular degeneration (AMD). METHODS: From January 2013 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration with a Predominantly Hemorrhagic Lesion
-
Cho YJ, Park SP
- KMID: 2214709
- J Korean Ophthalmol Soc.
- 2011 Jul;52(7):838-845.
- doi: 10.3341/jkos.2011.52.7.838
PURPOSE: To report the efficacy and safety of intravitreal ranibizumab monotherapy in patients with age-related macular degeneration with a predominantly hemorrhagic lesion. METHODS: Nineteen eyes of 19 patients with submacular hemorrhage... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Efficacy of Intravitreal Ranibizumab for Myopic Choroidal Neovascularization
-
Song MH, Kim JY, Roh YJ
- KMID: 2212490
- J Korean Ophthalmol Soc.
- 2009 Jul;50(7):1027-1034.
- doi: 10.3341/jkos.2009.50.7.1027
PURPOSE: To evaluate the effects of intravitreal ranibizumab in myopic choroidal neovascularization (CNV). METHODS: Patients who underwent intravitreal ranibizumab injection for myopic CNV, and were followed up more than 6... -
- CITED
-
- Close
- SHARE
-
- Close
- Macular Hole Following Intravitreal Ranibizumab Injections for Choroidal Neovascularization
-
Jo YJ, Kim KN, Lee JE, Kim JY
- KMID: 2425097
- J Korean Ophthalmol Soc.
- 2010 May;51(5):774-778.
PURPOSE: To report a case of macular hole following intravitreal ranibizumab injection in choroidal neovascularization associated with age-related macular degeneration. CASE SUMMARY: A 73-year-old man was referred for a sudden decline... -
- CITED
-
- Close
- SHARE
-
- Close
- The Short-Term Efficacy of Intravitreal Ranibizumab for Macular Edema in Central Retinal Vein Occlusion
-
Shin HY, Jee DH
- KMID: 2337976
- J Korean Ophthalmol Soc.
- 2011 Sep;52(9):1048-1054.
PURPOSE: To evaluate the short-term efficacy of intravitreal ranibizumab injection in eyes with macular edema secondary to central retinal vein occlusion (CRVO). METHODS: The records of 17 patients (17 eyes, 11... -
- CITED
-
- Close
- SHARE
-
- Close
- Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience
-
Ozkaya A, Alkin Z, Togac M, Ahmet S, Perente I, Taskapili
- KMID: 2390285
- Korean J Ophthalmol.
- 2017 Oct;31(5):424-430.
- doi: 10.3341/kjo.2016.0125
PURPOSE: To evaluate the outcomes of 5-year ranibizumab treatment in neovascular age-related macular degeneration (nAMD) in a single center and real life clinical setting. METHODS: The records of nAMD patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Choroidal Thickness Change between Ranibizumab and Aflibercept in Age-related Macular Degeneration: Six Month Results
-
Kim IG, Kim YI, Kim JS, Lee JH, Lee KW, Kang HG
- KMID: 2371910
- J Korean Ophthalmol Soc.
- 2017 Mar;58(3):296-304.
- doi: 10.3341/jkos.2017.58.3.296
PURPOSE: To compare the changes in subfoveal choroidal thickness between intravitreal aflibercept and ranibizumab injection in wet age-related macular degeneration (AMD). METHODS: Fifty patients with wet AMD patients who were treated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multimodal Approach to Diabetic Macular Edema
-
Lee JE
- KMID: 2350364
- Hanyang Med Rev.
- 2016 Aug;36(3):151-154.
- doi: 10.7599/hmr.2016.36.3.151
Diabetic macular edema is one of the most common causes of visual acuity impairment in adults. Various treatment modalities are currently used. They include laser therapy, intravitreal or periocular injection... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
-
Min JS, Jung HC, Suh JY, Kwon YH
- KMID: 2357729
- J Korean Ophthalmol Soc.
- 2016 Nov;57(11):1738-1744.
- doi: 10.3341/jkos.2016.57.11.1738
PURPOSE: To investigate the difference of optical coherence tomography (OCT) findings between the aflibercept treatment group and the ranibizumab treatment group. METHODS: This study includes patients diagnosed with treatment-naïve neovascular age-related... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration
-
Kang S, Cho WK, Roh YJ
- KMID: 2212308
- J Korean Ophthalmol Soc.
- 2009 May;50(5):725-730.
- doi: 10.3341/jkos.2009.50.5.725
PURPOSE: To report 1-year clinical changes in visual acuity (VA) after intravitreal ranibizumab therapy for choroidal neovascularization (CNV) due to age-related macular degeneration (AMD), and to determine differences in treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Short-Term Clinical Outcomes between Intravitreal Ranibizumab and Aflibercept in Retinal Angiomatous Proliferation
-
Kim OJ, Kim JH, Kim JW, Lee TG, Cho SW, Lee DW, Han JI, Kim CG
- KMID: 2213665
- J Korean Ophthalmol Soc.
- 2016 Feb;57(2):243-247.
- doi: 10.3341/jkos.2016.57.2.243
PURPOSE: To evaluate the 6-month outcomes of intravitreal ranibizumab and aflibercept treatment for patients with retinal angiomatous proliferation (RAP). METHODS: A retrospective review of medical records of 28 patients (31 eyes)... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Exudative Age-related Macular Degeneration and Projections of the Cost of Ranibizumab in Korea
-
Ryu S, Kim DW, Rim TH, Chung EJ, Kim J
- KMID: 2440453
- J Korean Ophthalmol Soc.
- 2019 Mar;60(3):253-260.
- doi: 10.3341/jkos.2019.60.3.253
PURPOSE: To analyze the incidence and prevalence of exudative age-related macular degeneration (AMD) and to predict the future AMD populations and health expenditures of intravitreal ranibizumab injection. METHODS: From 2010 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Ranibizumab, Bevacizumab, and Aflibercept on Senescent Retinal Pigment Epithelial Cells
-
Chae JB, Rho CR, Shin JA, Lyu J, Kang S
- KMID: 2418154
- Korean J Ophthalmol.
- 2018 Aug;32(4):328-338.
- doi: 10.3341/kjo.2017.0079
PURPOSE: Anti-vascular endothelial growth factor (VEGF) agents have been used for the last 10 years, but their safety profile, including cytotoxicity against various ocular cells such as retinal pigment epithelial... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration
-
Lee IH, Lee JJ, Kwon HJ, Park SW, Lee JE
- KMID: 2431838
- J Korean Ophthalmol Soc.
- 2019 Jan;60(1):40-46.
- doi: 10.3341/jkos.2019.60.1.40
PURPOSE: This study was performed to investigate the changes in clinical findings after switching from ranibizumab or aflibercept to bevacizumab due to the limited number of insured injections in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated for Age-Related Macular Degeneration
-
Lee JJ, Lew YJ, Cho SW, Kim JW
- KMID: 2338479
- J Korean Ophthalmol Soc.
- 2013 Oct;54(10):1534-1539.
PURPOSE: To investigate the development of new choroidal neovascularization in fellow eyes of patients treated for unilateral exudative age-related macular degeneration (AMD). METHODS: Three hundred fourteen patients who were first diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
